A1 Refereed original research article in a scientific journal

Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor beta via p38 mitogen-activated protein kinase.




AuthorsRavanti L., Toriseva M., Penttinen R., Crombleholme T., Foschi M., Han J., Kähäri V.

Publication year2001

JournalFASEB Journal

Journal name in sourceThe FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volume15

Issue6

First page 1098

Last page1100

ISSN0892-6638

Web address http://api.elsevier.com/content/abstract/scopus_id:0035318547


Abstract

Human collagenase-3 (MMP-13) is characterized by wide substrate specificity and limited tissue

specific expression. We have previously noted that human collagenase-3 (MMP-13) is expressed

by gingival fibroblasts in culture and during gingival wound repair characterized by minimal

scarring. Here we show that human MMP-13 is expressed by dermal fibroblasts during early

wound repair in fetal skin grafted on SCID mice. The expression of MMP-13 by fetal skin

fibroblasts in monolayer culture was enhanced by transforming growth factor

β

1 (TGF-

β

1) and

TGF-

β

3, whereas MMP-13 expression was not detected in neonatal skin fibroblasts. Treatment

of fetal skin fibroblasts with TGF-

β

1 potently activated p38 mitogen-activated protein kinase

(MAPK). Induction of MMP-13 expression by TGF-

β

1 was blocked by p38 MAPK inhibitor

SB203580, and by adenovirally delivered dominant negative form of p38

α

. These observations

demonstrate a remarkable difference in the regulation of collagenolytic capacity between fetal

and neonatal skin fibroblasts, which suggests a role for MMP-13 in rapid turnover of

collagenous matrix during repair of fetal cutaneous wounds, which heal without scar.

Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 22:46